Pathologies currently identified by exhaled biomarkers

Respiratory Physiology and Neurobiology

Volumn 187, Issue 1, 2013, Pages 128-134

  Mazzatenta, Andrea ^a,b   Di Giulio, Camillo ^a   Pokorski, Mieczyslaw ^c,d  

^a UNIVERSITY OF CHIETI   (Italy)

^b National Research Center   (Italy)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d UNIVERSITY OF OPOLE   (Poland)

Author keywords

Brain diseases; Chronic fatigue; Cognition; Exhaled breath; Oxidative stress; Volatile organic compounds (VOCs)

Indexed keywords

ACETALDEHYDE; ACETONE; ALCOHOL; ALIPHATIC AMINE; AMMONIA; BIOLOGICAL MARKER; BROMODICHLOROMETHANE; CARBON DIOXIDE; CARBON MONOXIDE; CHLOROFORM; DIMETHYL SULFIDE; ETHYLENE; GLUTATHIONE; HYDROGEN CYANIDE; HYDROGEN PEROXIDE; ISOPRENE; ISOPROSTANE DERIVATIVE; LEUKOTRIENE; MALONALDEHYDE; METAL OXIDE; METHANE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTANOID; SULFIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRICHLOROETHYLENE; UREA; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUND;

AGING; ASTHMA; BLOOD CARBON DIOXIDE TENSION; BREATH ANALYSIS; CANCER DIAGNOSIS; CAPNOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; DIABETES MELLITUS; ELECTROCHEMISTRY; EXHALATION; FATIGUE; FORCED EXPIRATORY VOLUME; GAS CHROMATOGRAPHY; HUMAN; HYDROGEN BREATH TEST; INFLAMMATION; ION MOBILITY SPECTROMETRY; LUNG CANCER; LUNG TRANSPLANTATION; MASS SPECTROMETRY; MULTIPLE CHEMICAL SENSITIVITY; NANOSENSOR; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEMICONDUCTOR; SLEEP DISORDERED BREATHING; UREA BREATH TEST;

BIOLOGICAL MARKERS; BREATH TESTS; HUMANS; VOLATILE ORGANIC COMPOUNDS;

EID: 84877925330     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.02.016     Document Type: Review

References (62)

1. Aghdassi E., Allard J.P. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radical Biology and Medicine 2000, 28:880-886.
2. ATS/ERS ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine 2005, 171:912-930.
3. Amann A., Miekisch W., Pleil J., Risby T., Schubert J. Methodological issues of sample collection and analysis of exhaled breath. European Respiratory Monograph: Exhaled Biomarkers 2010, 96-114. I. Horvath, J.C. de Jongste (Eds.).
4. Ashok B.T., Ali R. The aging paradox: free radical theory of aging. Experimental Gerontology 1999, 34:293-303.
5. Balseiro S.C., Correia H.R. Is olfactory detection of human cancer by dogs based on major histocompatibility complex-dependent odour components? A possible cure and a precocious diagnosis of cancer. Medical Hypotheses 2006, 66:270-272.
6. Cao W., Duan Y. Breath analysis: potential for clinical diagnosis and exposure assessment. Clinical Chemistry 2006, 52:800-811.
7. Carpagnano G.E. Exhaled breath analysis and sleep. Journal of Clinical Sleep Medicine 2011, 7(5):S34-S37.
8. Chen S., Zieve L., Mahadevan V. Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine. Journal of Laboratory and Clinical Medicine 1970, 75:628-635.
9. Christie J.D., Edwards L.B., Aurora P., Dobbels F., Kirk R., Rahmel A.O., Taylor D.O., Kucheryavaya A.Y., Hertz M.I. Registry for the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report. Journal of Heart and Lung Transplantation 2008, 27:943-956.
10. Clini E., Bianchi L., Pagani M., Ambrosino N. Endogenous nitric oxide in stable COPD patients: correlates with severity of disease. Thorax 1998, 53:881-883.
11. Cope K.A., Watson M.T., Foster W.M., Sehnert S.S., Risby T.H. Effects of ventilation on the collection of exhaled breath in humans. Journal of Applied Physics 2004, 96:1371-1379.
12. Crofford O.B., Mallard R.E., Winton R.E., Rogers N.L., Jackson J.C., Keller U. Acetone in breath and blood. Transactions of the American Clinical and Climatological Association 1977, 88:128-139.
13. Dahl M., Nordestgaard B.J. Markers of early disease and prognosis in COPD. International Journal of COPD 2009, 4:157-167.
14. Dannecker J.R., Shaskan E.G., Phillips M. A new highly sensitive assay for breath acetaldehyde: detection of endogenous levels in humans. Analytical Biochemistry 1981, 114:1-7.
15. Di Natale C., Macagnano A., Martinelli E., Paolesse R., D'Arcangelo G., Roscioni C., Finazzi-Agrò A., D'Amico A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosensors and Bioelectronics 2003, 18:1209-1218.
16. Dumelin E.E., Tappel A.L. Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides. Lipids 1977, 12:894-900.
17. Dweik R.A., Boggs P.B., Erzurum S.C., Irvin C.G., Leigh M.W., Lundberg J.O., Olin A.C., Plummer A.L., Taylor D.R. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. American Journal of Respiratory and Critical Care Medicine 2011, 184:60615.
18. Fisher A.J., Gabbay E., Small T., Doig S., Dark J.H., Corris P.A. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998, 53:454-458.
19. Gendron K.B., Hockstein N.G., Thaler E.R., Vachani A., Hanson C.W. In vitro discrimination of tumor cell lines with an electronic nose. Otolaryngology - Head and Neck Surgery 2007, 137:269-273.
20. Hadjiliadis D., Davis R.D., Steele M.P., Messier R.H., Lau C.L., Eubanks S.S., Palmer S.M. Gastro-esophageal reflux disease in lung transplant recipients. Clinical Transplantation 2003, 17:363-368.
21. Henderson M.J., Karger B.A., Wren Shall G.A. Acetone in the breath: a study of acetone exhalation in diabetic and nondiabetic human subjects. Diabetes 1952, 1:188-193.
22. Horvath I., Hunt J., Barnes P.J. Exhaled breath condensate: methodological recommendations and unresolved questions. European Respiratory Journal 2005, 26:523-548. on behalf of the ERS/ATS Task Force.
23. Horvath I., Lazar Z., Gyulai N., Kollai M., Losonczy G. Exhaled biomarkers in lung cancer. European Respiratory Journal 2009, 34:261-275.
24. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. Journal of Allergy and Clinical Immunology 2002, 110:28-34.
25. Jansson B.O., Larsson B.T. Analysis of organic compounds in human breath by gas chromatography-mass spectrometry. Journal of Laboratory and Clinical Medicine 1969, 74:961-966.
26. Lases E.C., Duurkens V.A.M., Gerritsen W.B., Haas F.J. Oxidative stress after lung resection therapy: a pilot study. Chest 2000, 117:999-1003.
27. Machado R.F., Laskowski D., Deffenderfer O., Burch T., Zheng S., Mazzone P.J., Mekhail T., Jennings C., Stoller J.K., Pyle J., Duncan J., Dweik R.A., Erzurum S.C. Detection of lung cancer by sensor array analyses of exhaled breath. American Journal of Respiratory and Critical Care Medicine 2005, 171:1286-1291.
28. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006, 3:e442.
29. Mazzatenta A., Pokorski M., Cozzutto S., Barbieri P., Veratti V., Di Giulio C. Non-invasive assessment of exhaled breath pattern in patients with multiple chemical sensibility disorder. Advances in Experimental Medicine and Biology 2013, 756:179-188.
30. Mazzatenta, A., Pokorski, M., Di Giulio, C., 2013b. Real-time breath analysis in type 2 diabetes mellitus patients during cognitive task. Advances in Experimental Medicine and Biology 788, Chapter 35, in press.
31. Mazzone P.J., Hammel J., Dweik R., Na J., Czich C., Laskowski D., Mekhail T. Lung cancer diagnosis by the analysis of exhaled breath with a colorimetric sensor array. Thorax 2007, 62:565-568.
32. Metidiewa D., Koska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurological disorders: an overview. Neurotoxicity Research 2000, 1:197-233.
33. Miekisch W., Schubert J.K., Noeldge-Schomburg G.F. Diagnostic potential of breath analysis: focus on volatile organic compounds. Clinica Chimica Acta 2004, 347:25-39.
34. Montag S., Frank M., Ulmer H., Wernet D., Göpel W., Rammensee H.G. " Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:9249-9254.
35. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clinica Chimica Acta 2005, 356:22-34.
36. Montuschi P., Kharitonov S.A., Ciabattoni G., Corradi M., van Rensen L., Geddes D.M., Hodson M.E., Barnes P.J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000, 55:205-209.
37. Olin A.C., Rosengren A., Thelle D.S., Lissner L., Bake B., Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006, 130:1319-1325.
38. Orens J.B., Garrity E.R. General overview of lung transplantation and review of organ allocation. Proceedings of the American Thoracic Society 2009, 6:13-19.
39. Pauling L., Robinson A.B., Teranishi R., Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proceedings of the National Academy of Sciences of the United States of America 1971, 68:2374-2376.
40. Perman J.A. Clinical application of breath hydrogen measurements. Canadian Journal of Physiology and Pharmacology 1991, 69:111-115.
41. Phillips M. Breath tests in medicine. Scientific American 1992, 267:74-79.
42. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Analytical Biochemistry 1997, 247:272-278.
43. Phillips M., Cataneo R.N., Cheema T., Greenberg J. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clinica Chimica Acta 2004, 344:189-194.
44. Phillips M., Cataneo R.N., Cummin A.R.C., Gagliardi A.J., Gleeson K., Greenberg J., Maxfield R.A., Rom W.N. Detection of lung cancer with volatile markers in the breath. Chest 2003, 123:2115-2123.
45. Phillips M., Herrera J., Krishnan S., Zain M., Greenberg J., Cataneo R.N. Variation in volatile organic compounds in the breath of normal humans. Journal of Chromatography B: Biomedical Sciences and Applications 1999, 729:75-88.
46. Radhika V., Proikas-Cezanne T., Jayaraman M., Onesime D., Ha J.H., Dhanasekaran D.N. Chemical sensing of DNT by engineered olfactory yeast strain. Nature Chemical Biology 2007, 3:325-330.
47. Riely C.A., Cohen G., Lieberman M. Ethane evolution: a new index of lipid peroxidation. Science 1974, 183:208-210.
48. Risby T.H. Volatile organic compounds as markers in normal and diseased states. Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications. NATO ASI Series 2002, 113-122. IOS Press, Amsterdam. N. Marczin, M. Yacoub (Eds.).
49. Risby T.H., Sehnert S.S. Clinical application of breath biomarkers of oxidative stress status. Free Radical Biology and Medicine 1999, 27:1182-1192.
50. Risby T.H., Solga S.F. Current status of clinical breath analysis. Applied Physics B 2006, 85:421-426.
51. Romagnuolo J., Schiller D., Bailey R.J. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. American Journal of Gastroenterology 2002, 97:1113-1126.
52. Rosias P.P.R., Dompeling E., Dentener M.A., Pennings H.J., Hendriks H.J., Van Iersel M.P., Van Iersel M.P., Jöbsis Q. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatric Pulmonology 2004, 38:107-114.
53. Skeldon K.D., McMillan L.C., Wyse C.A., Monk S.D., Gibson G., Patterson C., France T., Longbottom C., Padgett M.J. Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer. Respiratory Medicine 2006, 100:300-306.
54. Smith D., Spanel P., Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. Journal of Applied Physiology 1999, 87:1584-1588.
55. Solga S.F., Risby T.H. What is normal breath? Challenge and opportunity. IEEE Sensors Journal 2010, 10:7-9.
56. Spanel P., Smith D. Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS. Journal of Breath Research 2008, 2:046003.
57. Sysoev V.V., Button B.K., Wepsiec K., Dmitriev S., Kolmakov A. Toward the nanoscopic " electronic nose": hydrogen versus carbon monoxide discrimination with an array of individual metal oxide nano- and mesowire sensors. Nano Letters 2006, 6:1584-1588.
58. Szefler S.J., Martin R.J., King T.S., Boushey H.A., Cherniack R.M., Chinchilli V.M., Craig T.J., Dolovich M., Drazen J.M., Fagan J.K., Fahy J.V., Fish J.E., Ford J.G., Israel E., Kiley J., Kraft M., Lazarus S.C., Lemanske R.F., Mauger E., Peters S.P., Sorkness C.A. Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. Journal of Allergy and Clinical Immunology 2002, 109:410-418.
59. Szefler S.J., Wenzel S., Brown R., Erzurum S.C., Fahy J.V., Hamilton R.G., Hunt J.F., Kita H., Liu A.H., Panettieri R.A., Schleimer R.P., Minnicozzi M. Asthma outcomes: biomarkers. Journal of Allergy and Clinical Immunology 2012, 129:S9-S23.
60. Thorpe M.J., Balslev-Clausen D., Kirchner M.S., Ye J. Cavity enhanced optical frequency comb spectroscopy: application to human breath analysis. Optics Express 2008, 18:2387-2397.
61. Vidic J.M., Grosclaude J., Persuy M.A., Aioun J., Salesse R., Pajot-Augy E. Quantitative assessment of olfactory receptors activity in inmobilized nanosomes: a novel concept for bioelectronic nose. Lab on a Chip 2006, 6:1026-1032.
62. Williams H., Pembroke A. Sniffer dogs in the melanoma clinic?. Lancet 1989, 1:734.